• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未分化鼻咽癌患者血浆骨桥蛋白水平升高。

Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.

作者信息

Wong T S, Kwong D L-W, Sham J, Wei W I, Kwong Y L, Yuen A P-W

机构信息

Department of Surgery, The University of Hong Kong, Hong Kong, China.

出版信息

Eur J Surg Oncol. 2005 Jun;31(5):555-8. doi: 10.1016/j.ejso.2005.01.005.

DOI:10.1016/j.ejso.2005.01.005
PMID:15922893
Abstract

AIMS

We evaluated the clinicopathologic relevance of plasma osteopontin (OPN) level in nasopharyngeal carcinoma patients.

METHODS

Seventy-two plasma samples were collected from patients with undifferentiated nasopharyngeal carcinoma (NPC) before radiotherapy. Plasma OPN level was determined by quantitative sandwich enzyme immunoassay. The plasma OPN level was evaluated for its clinicopathologic relevance.

RESULTS

The mean plasma OPN level was significantly higher in NPC patients than in normal controls (184.66 vs 75.89 ng/ml, p<0.001). In addition, high OPN level was found in the patients with advanced cancer and was correlated with neck node metastasis (p<0.05).

CONCLUSIONS

Our findings indicated a potential role of OPN in the pathogenesis and nodal metastasis of undifferentiated NPC.

摘要

目的

我们评估了鼻咽癌患者血浆骨桥蛋白(OPN)水平的临床病理相关性。

方法

收集72例未分化鼻咽癌(NPC)患者放疗前的血浆样本。采用定量夹心酶免疫测定法测定血浆OPN水平。评估血浆OPN水平的临床病理相关性。

结果

NPC患者的血浆OPN平均水平显著高于正常对照组(184.66对75.89 ng/ml,p<0.001)。此外,晚期癌症患者的OPN水平较高,且与颈部淋巴结转移相关(p<0.05)。

结论

我们的研究结果表明OPN在未分化NPC的发病机制和淋巴结转移中具有潜在作用。

相似文献

1
Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.未分化鼻咽癌患者血浆骨桥蛋白水平升高。
Eur J Surg Oncol. 2005 Jun;31(5):555-8. doi: 10.1016/j.ejso.2005.01.005.
2
Clinical significance of elevated osteopontin levels in head and neck cancer patients.头颈部癌症患者骨桥蛋白水平升高的临床意义
Auris Nasus Larynx. 2007 Sep;34(3):343-6. doi: 10.1016/j.anl.2006.11.012. Epub 2007 Jan 24.
3
Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.肝细胞癌患者血浆骨桥蛋白水平升高。
Am J Gastroenterol. 2006 Sep;101(9):2051-9. doi: 10.1111/j.1572-0241.2006.00679.x. Epub 2006 Jul 18.
4
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.血浆骨桥蛋白、缺氧与鼻咽癌放疗反应
Clin Cancer Res. 2008 Nov 1;14(21):7080-7. doi: 10.1158/1078-0432.CCR-08-0364.
5
Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma.
Eur J Surg Oncol. 2004 Jun;30(5):560-4. doi: 10.1016/j.ejso.2004.02.007.
6
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.血浆骨桥蛋白:与激素难治性前列腺癌男性患者的生存及骨转移的关联
Cancer. 2002 Aug 1;95(3):506-12. doi: 10.1002/cncr.10709.
7
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.转移性乳腺癌患者血浆骨桥蛋白水平升高与肿瘤负荷增加及生存率降低相关。
Clin Cancer Res. 1997 Apr;3(4):605-11.
8
[The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma].[术前骨桥蛋白血浆水平联合细胞间黏附分子-1对肝细胞癌患者的预后意义]
Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):985-8.
9
Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.术前血浆骨桥蛋白水平作为一种生物标志物,在预测卵巢癌方面可作为糖类抗原125的补充。
J Obstet Gynaecol Res. 2006 Jun;32(3):309-14. doi: 10.1111/j.1447-0756.2006.00403.x.
10
Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.接受放化疗的头颈癌患者的血浆骨桥蛋白水平
Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):807-11. doi: 10.1001/archoto.2009.103.

引用本文的文献

1
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.血浆缺氧标志物在预测接受根治性放化疗的头颈癌患者基于影像学的缺氧情况中的价值。
Clin Transl Radiat Oncol. 2022 Feb 21;33:120-127. doi: 10.1016/j.ctro.2022.02.008. eCollection 2022 Mar.
2
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.骨桥蛋白:肿瘤进展与免疫调节的关键调节因子
Cancers (Basel). 2020 Nov 15;12(11):3379. doi: 10.3390/cancers12113379.
3
Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
美国中 Epstein-Barr 病毒相关的鼻咽癌发病率上升。
Cancer. 2020 Jan 1;126(1):121-130. doi: 10.1002/cncr.32517. Epub 2019 Sep 16.
4
The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin.细胞外ATP通过P2Y2受体和骨桥蛋白对鼻咽癌细胞生长的抑制作用
J Exp Clin Cancer Res. 2014 Jun 24;33(1):53. doi: 10.1186/1756-9966-33-53.
5
Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.骨桥蛋白基因多态性与鼻咽癌风险的相关性。
Med Oncol. 2014 Jul;31(7):20. doi: 10.1007/s12032-014-0020-x. Epub 2014 Jun 10.
6
Serum levels of osteopontin as a prognostic factor in patients with oral squamous cell carcinoma.血清骨桥蛋白水平作为口腔鳞状细胞癌患者的预后因素
Tumour Biol. 2014 Apr;35(4):3827-9. doi: 10.1007/s13277-013-1506-4. Epub 2013 Dec 14.
7
Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer.骨桥蛋白循环水平升高与晚期非小细胞肺癌转移相关。
Chin J Cancer Res. 2011 Mar;23(1):64-8. doi: 10.1007/s11670-011-0064-9.
8
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.血浆骨桥蛋白升高作为肾细胞癌患者远处转移和生存不良的标志物。
J Cancer Res Clin Oncol. 2007 Sep;133(9):643-52. doi: 10.1007/s00432-007-0215-z. Epub 2007 May 4.
9
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.鼻咽癌:分子生物标志物的发现与进展
Mol Cancer. 2007 Jan 2;6:1. doi: 10.1186/1476-4598-6-1.
10
Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.头颈癌和宫颈癌患者血浆骨桥蛋白水平严重依赖于酶联免疫吸附测定(ELISA)系统的选择。
BMC Cancer. 2006 Aug 15;6:207. doi: 10.1186/1471-2407-6-207.